Two major problems for magnesium alloy implant are the high degradation rate and easy infection associated with implantation. Herein, a surface drug delivery system (Mg/Epoxy resin-ZnO/PCL-Ibuprofen) which can realize bi-directional controlled release of ibuprofen and Mg2+ was designed via a dip coating process followed by spraying. The in vitro test demonstrated that the ibuprofen in drug-eluting compound material showed sustained release profiles for 22days, which can effectively solve the local cellular rejection and inflammation during the early stage of implantation. Besides, the drug carrier also exhibited improved corrosion resistance duel to the high combining strength between Epoxy resin-ZnO coating and magnesium alloy, so Mg2+ can release slowly at first and then speeded up later. This approach may be suitable for coating other implant materials such as stainless steel, titanium alloy etc.
Read full abstract